OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Bladder Cancer|Breast Cancer|Kidney Cancer|Lung Cancer|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: custirsen sodium|DRUG: docetaxel|OTHER: pharmacological study
Sponsor: NCIC Clinical Trials Group